Domain Associates
Founded in 1985, Domain Associates, L.L.C. is a venture capital firm with an exclusive focus on life sciences. With $2 billion of capital under management, Domain is headquartered in Princeton, NJ with a second office in San Diego, CA.
Domain’s three major investment segments are pharmaceuticals, specialty pharmaceuticals, and medical devices, while additional areas of interest include biomaterials, bioinstrumentation, and diagnostics. The Partners of Domain have a total of close to 200 person-years of experience among them in the healthcare/venture capital industries and have been involved in the formation and growth of more than 200 life-sciences companies. The highly focused network, experience, and reputation of this team have made it one of the top private-equity groups participating in the healthcare field.
Milestones
-
Posted 11/12/09 at 10:15pm
-
Posted 11/11/09 at 4:18pm
-
Posted 10/21/09 at 6:23pm
-
Domain Associates invested in
Zogenix.
(9/23/09)
Posted 9/24/09 at 2:04am
-
Posted 7/20/09 at 12:29pm
-
Posted 6/17/09 at 11:15am
-
Posted 6/24/09 at 1:40pm
-
Posted 4/10/09 at 6:30am
-
Posted 4/21/09 at 5:30pm
-
Domain Associates invested in
Glaukos.
(8/29/08)
Posted 6/22/09 at 8:17pm
-
Posted 12/31/08 at 8:59pm
-
Posted 6/5/09 at 2:19am
-
Posted 6/3/09 at 10:56pm
-
Posted 6/29/09 at 2:16am
-
Domain Associates invested in
Corthera.
(12/20/07)
Posted 7/13/09 at 9:10pm
-
Domain Associates invested in
DiObex.
(4/16/07)
Posted 9/16/09 at 7:45am
Investments
Videos
Sources
-
PeHub (pehub.com) [edit]
-
Microchip Biotechnologies Raises $18.1M in Series B Financing (sanfrancisco.bizjournals.com)
[edit]
-
Altair (altairthera.com)
[edit]
-
Alimera Sciences, Inc.: Series C $5M (onbiovc.com)
[edit]
-
Zogenix rounds up $51M for product roll-out (fiercebiotech.com)
[edit]
-
Oraya garners $42M in third venture round (fiercebiotech.com)
[edit]
-
Clovis Oncology (Boulder, CO) an entity focused on licensing or acquiring rights to oncology compounds in all stages of clinical development (onbiovc.com)
[edit]
-
Marinus Pharmaceuticals, Inc.: Series B $20M (onbiovc.com)
[edit]
-
Cell Biosciences Raises $10 Million (pehub.com)
[edit]
-
BiPar Sciences Raises $20 Million to Advance Clinical Programs (biparsciences.com)
[edit]
-
Glaukos Adds $35 Million (equityhelpdesk.com)
[edit]
-
Equity Help Desk (equityhelpdesk.com)
[edit]
-
Capital Funding Report
[edit]
-
Esperion Therapeutics Completes $22.75M Series A Financing (esperion.com)
[edit]
-
Nuon Therapeutics, Inc. Completes $27 Million Series B Financing (nuontherapeutics.com)
[edit]
-
Corthera Closes $23 Million Financing Round (basmedical.com)
[edit]
-
DiObex, a metabolic disease treatment co., raises $24M (deals.venturebeat.com)
[edit]
-
BiPar Sciences Raises $35 Million to Advance Pipeline of Novel PARP Inhibitor Cancer Drug Candidates (biparsciences.com)
[edit]
-
Bio-Medicine (bio-medicine.org)
[edit]